| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |